Treatment options
Established treatment for significant contracture is surgical. That is an uncomfortable answer, and it is the reason a large market exists for alternatives that do not work.
The short answer
For Baker III and IV contracture, the treatment with evidence behind it is surgery to remove the capsule, with or without removing or replacing the implant. Mild contracture is often monitored rather than treated. No medication, massage regime, supplement or device has been established as a reliable non-surgical cure.
Surgical options
These are the approaches a surgeon will discuss. Which is appropriate depends on the grade, on whether you want implants afterwards, and on what is found during the operation.
- Capsulectomy with removal. The capsule is removed and the implant is not replaced. This is the route most people who come to this site are considering, and it is covered in detail on our explant surgery pages.
- Capsulectomy with replacement. Capsule removed and a new implant placed, often in a different plane — for example moving from above to beneath the muscle — on the reasoning that changing the pocket lowers the chance of recurrence.
- Capsulotomy. The capsule is cut to release the tightness rather than removed. A smaller operation, and generally regarded as having a higher chance of the problem returning than removing the capsule.
The 2024 Breast Surgery Collaborative Community consensus, endorsed by ASPS, The Aesthetic Society and ISAPS, defines these techniques and their indications. En bloc capsulectomy specifically is reserved for suspected or confirmed implant-associated cancer, not used as the default for contracture.
That last point matters if you have read community advice telling you to insist on en bloc. Our page on whether you need en bloc explains why the useful question is whether the whole capsule comes out, not whether it comes out in one piece.
Does it come back?
Contracture can recur after treatment, and recurrence is a recognised outcome rather than a rare surprise. Reported recurrence rates vary considerably between studies and depend heavily on the technique used, whether an implant was replaced, and how long patients were followed.
This is a reasonable thing to ask your surgeon about directly: what their recurrence rate is, how they track it, and what they would do differently if it returned. It is also a genuine argument in favour of removal without replacement for people who have already had contracture more than once.
The non-surgical claims
You will find a lot of confident marketing here. Being straight about what the evidence supports:
Leukotriene receptor antagonists — asthma medications such as montelukast and zafirlukast — have been used off-label for capsular contracture, and some studies report improvement. The evidence base is limited, the drugs carry their own risks including neuropsychiatric side effects, and this is not an established treatment. It is a conversation for a physician, not a supplement aisle.
Implant massage, ultrasound therapy and various devices are widely promoted for preventing or reversing contracture. Evidence that any of them reliably reverses established contracture is weak, and recommendations differ between surgeons and by implant type.
Closed capsulotomy — squeezing the breast forcefully to rupture the capsule from outside — was historically performed and is now generally avoided. It can rupture the implant, and manufacturers have voided warranties over it. If anyone proposes it, ask why.
We do not sell supplements and we do not publish detox protocols. If a page offering to cure contracture is also selling you something, that is the explanation for the page.
Doing nothing
For grade I and II contracture, monitoring is a legitimate plan rather than a failure to act. Many people have mild contracture that stays stable for years. Surgery has its own risks, and trading a firm breast for a surgical complication is not automatically a good exchange.
What changes the calculation is pain, progression, or a grade that has moved. Those are reasons to revisit the decision rather than reasons to panic.
Cost and coverage
Contracture is one of the stronger cases for insurance or provincial coverage, because it is a recognised medical complication rather than a cosmetic preference — particularly at Baker III and IV, and particularly with documentation. Our cost page covers what is usually funded, what is not, and what to get in writing before you commit.
- Breast Surgery Collaborative Community. Consensus statement on breast implant capsulectomy definitions and management, 2024.
- U.S. Food and Drug Administration. Breast implant labelling recommendations, boxed warning and patient decision checklist, October 2021.